In vitro synergy and antagonism of antifungal agents against yeast-like fungi
- PMID: 523360
- PMCID: PMC2425645
- DOI: 10.1136/pgmj.55.647.683
In vitro synergy and antagonism of antifungal agents against yeast-like fungi
Abstract
Some antifungal agents have been tested qualitatively in various associations against species of Candida, Cryptococcus and Torulopsis. The method used was the channel test and the results are confirmed by comparison with the serial dilution test in agar. The antagonism in vitro with the combination of amphotericin B imidazole suggests that caution must be exercised before prescribing the antifungal drugs in combination for man. The frequent synergy of flucytosine with econazole is, however, encouraging because of the low toxicity of the 2 drugs. Under the limited conditions described, the combination of flucytosine and amphotericin B was not found synergistic but additive on the strains of C. albicans used in this study. This combination was found synergistic for a strain of C. parapsilosis and is useful for avoiding resistance to flucytosine.
Similar articles
-
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].Ann Biol Clin (Paris). 1989;47(9):546-9. Ann Biol Clin (Paris). 1989. PMID: 2558599 French.
-
[Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].Pathol Biol (Paris). 1986 May;34(5):536-9. Pathol Biol (Paris). 1986. PMID: 3534739 French.
-
In vitro activity of antifungal agents against yeast species.Chemotherapy. 1983;29(2):104-10. doi: 10.1159/000238182. Chemotherapy. 1983. PMID: 6301773
-
A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.Sabouraudia. 1982 Dec;20(4):313-23. Sabouraudia. 1982. PMID: 7157107
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
Cited by
-
Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.Antimicrob Agents Chemother. 1989 May;33(5):717-25. doi: 10.1128/AAC.33.5.717. Antimicrob Agents Chemother. 1989. PMID: 2665643 Free PMC article.
-
Compounds active against cell walls of medically important fungi.Clin Microbiol Rev. 1993 Jan;6(1):1-21. doi: 10.1128/CMR.6.1.1. Clin Microbiol Rev. 1993. PMID: 8457977 Free PMC article. Review.
-
Entry of ketoconazole into Candida albicans.Antimicrob Agents Chemother. 1987 Feb;31(2):244-8. doi: 10.1128/AAC.31.2.244. Antimicrob Agents Chemother. 1987. PMID: 3551831 Free PMC article.
-
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.Virulence. 2015;6(4):362-71. doi: 10.1080/21505594.2015.1039885. Virulence. 2015. PMID: 26048362 Free PMC article. Review.
-
Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro.Antimicrob Agents Chemother. 1995 Aug;39(8):1779-83. doi: 10.1128/AAC.39.8.1779. Antimicrob Agents Chemother. 1995. PMID: 7486918 Free PMC article.